Evidence map›Paper›PMID 34848384›Full record

ArticleBiological psychiatry. Cognitive neuroscience and neuroimaging2023

A Comprehensive Analysis of Cerebellar Volumes in the 22q11.2 Deletion Syndrome.

J Eric Schmitt, John J DeBevits, David R Roalf, Kosha Ruparel, R Sean Gallagher, Ruben C Gur, Aaron Alexander-Bloch, Tae-Yeon Eom, Shahinur Alam, Jeffrey Steinberg and 7 more

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry. Cognitive neuroscience and neuroimaging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Charting Brain Structure in 22q11.2 Deletion Syndrome with Clinical Neuroimaging.medRxiv : the preprint server for health sciences · 2026
    Article
  3. Article
  4. Review
  5. Mapping Cerebellar Morphology in 15q11.2 CNV Carriers Using Normative Modeling.medRxiv : the preprint server for health sciences · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

J Eric SchmittBrain Behavior Laboratory, Neurodevelopment and Psychosis Section, Department of Psychiatry, Philadelphia, Pennsylvania; Division of Neuroradiology, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: eric.schmitt@stanfordalumni.org.
John J DeBevitsDivision of Neuroradiology, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
David R RoalfBrain Behavior Laboratory, Neurodevelopment and Psychosis Section, Department of Psychiatry, Philadelphia, Pennsylvania.
Kosha RuparelBrain Behavior Laboratory, Neurodevelopment and Psychosis Section, Department of Psychiatry, Philadelphia, Pennsylvania.
R Sean GallagherBrain Behavior Laboratory, Neurodevelopment and Psychosis Section, Department of Psychiatry, Philadelphia, Pennsylvania.
Ruben C GurBrain Behavior Laboratory, Neurodevelopment and Psychosis Section, Department of Psychiatry, Philadelphia, Pennsylvania.
Aaron Alexander-BlochBrain Behavior Laboratory, Neurodevelopment and Psychosis Section, Department of Psychiatry, Philadelphia, Pennsylvania.
Tae-Yeon EomDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Shahinur AlamCenter for Bioimage Informatics, St. Jude Children's Research Hospital, Memphis, Tennessee.
Jeffrey SteinbergCenter for Bioimage Informatics, St. Jude Children's Research Hospital, Memphis, Tennessee.
Walter AkersCenter for Bioimage Informatics, St. Jude Children's Research Hospital, Memphis, Tennessee.
Khaled KhairyCenter for In Vivo Imaging and Therapeutics, St. Jude Children's Research Hospital, Memphis, Tennessee.
T Blaine CrowleyDivision of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Beverly EmanuelDepartment of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Stanislav S ZakharenkoDepartment of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Donna M McDonald-McGinnDepartment of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
Raquel E GurBrain Behavior Laboratory, Neurodevelopment and Psychosis Section, Department of Psychiatry, Philadelphia, Pennsylvania; Division of Neuroradiology, Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
St. Jude Children's Research Hospital · USHospital of the University of Pennsylvania · USChildren's Hospital of Philadelphia · US

Funding

Neurodevelopmental Genomics: Trajectories of Complex PhenotypesRC2MH089983 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 2009 to 2011
$14.3M
2/2 Neurodevelopmental Genomics: Trajectories of Complex PhenotypesRC2MH089924 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI HAKONARSON, HAKON · 2009 to 2011
$10.7M
1/2-Brain-Behavior and Genetic Studies of the 22q11DSU01MH087626 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 2010 to 2014
$6.5M
Synaptic mechanisms of auditory memoryR01DC012833 · NIDCD · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI ZAKHARENKO, STANISLAV S · 2013 to 2022
$4.2M
Towards understanding cellular mechanisms of positive symptoms of schizophreniaR01MH097742 · NIMH · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI ZAKHARENKO, STANISLAV S · 2013 to 2022
$4.1M
Ultra-high field GluCEST MRI and MRS in youth at risk for psychosisR01MH120174 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ROALF, DAVID R · 2020 to 2024
$3.8M
Olfactory and facial markers of developmental risk for psychosis in 22q11 deletion syndromeR01MH119185 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI ROALF, DAVID R · 2019 to 2024
$3.5M
The role of UBE3A in gliopathic seizuresR01NS115776 · NINDS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI REITER, LAWRENCE T, ZAKHARENKO, STANISLAV S · 2020 to 2024
$2.0M
Glutamate Chemical Exchange Saturation Transfer (GluCEST) Imaging in Cognitive AgingR56AG066656 · NIA · UNIVERSITY OF PENNSYLVANIA · PI ROALF, DAVID R · 2020 to 2020
$533k
NIA NIH HHS R56 AG066656NIDCD NIH HHS R01 DC012833NIMH NIH HHS R01 MH097742NIMH NIH HHS R01 MH119185NIMH NIH HHS R01 MH120174NIMH NIH HHS RC2 MH089924NIMH NIH HHS RC2 MH089983NIMH NIH HHS U01 MH087626NINDS NIH HHS R01 NS115776
6 · The paper itself

Abstract

backgroundThe presence of a 22q11.2 microdeletion (22q11.2 deletion syndrome [22q11DS]) ranks among the greatest known genetic risk factors for the development of psychotic disorders. There is emerging evidence that the cerebellum is important in the pathophysiology of psychosis. However, there is currently limited information on cerebellar neuroanatomy in 22q11DS specifically.

methodsHigh-resolution 3T magnetic resonance imaging was acquired in 79 individuals with 22q11DS and 70 typically developing control subjects (N = 149). Lobar and lobule-level cerebellar volumes were estimated using validated automated segmentation algorithms, and subsequently group differences were compared. Hierarchical clustering, principal component analysis, and graph theoretical models were used to explore intercerebellar relationships. Cerebrocerebellar structural connectivity with cortical thickness was examined via linear regression models.

resultsIndividuals with 22q11DS had, on average, 17.3% smaller total cerebellar volumes relative to typically developing subjects (p < .0001). The lobules of the superior posterior cerebellum (e.g., VII and VIII) were particularly affected in 22q11DS. However, all cerebellar lobules were significantly smaller, even after adjusting for total brain volumes (all cerebellar lobules p < .0002). The superior posterior lobule was disproportionately associated with cortical thickness in the frontal lobes and cingulate cortex, brain regions known be affected in 22q11DS. Exploratory analyses suggested that the superior posterior lobule, particularly Crus I, may be associated with psychotic symptoms in 22q11DS.

conclusionsThe cerebellum is a critical but understudied component of the 22q11DS neuroendophenotype.

Indexed as

DiGeorge SyndromePsychotic DisordersBrainBrain MappingCerebellumHumans22q11.2 deletion syndromeCerebellumCrus IGeneticsMRIPsychosisSchizophrenia

Identifiers

PMID34848384
PMCPMC9162086
OpenAlexW3217392949

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.